Early experience and assessment of real-world toxicities with mirvetuximab soravtansine in a heavily pretreated patient cohort with ovarian cancer by Susan M. Lang, Filippos Vingopoulos, Isabel Beshar, Sahana Somasegar, Elizabeth V. Adams, Simone A. Sasse, Talayeh Ghezelayagh, Emily Clair McClung, Amer Karam, Oliver Dorigo, Prithvi Mruthyunjaya, Babak Litkouhi

Get full text